Restoring the impaired cardiac calcium homeostasis and cardiac function in iron overload rats by the combined deferiprone and N-acetyl cysteine
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Restoring the impaired cardiac calcium homeostasis and cardiac function in iron overload rats by the combined deferiprone and N-acetyl cysteine
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-03-13
DOI
10.1038/srep44460
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats
- (2016) P. Tanajak et al. Acta Physiologica
- Association of cardiac injury with iron-increased oxidative and nitrative modifications of the SERCA2a isoform of sarcoplasmic reticulum Ca2+-ATPase in diabetic rats
- (2016) Xueli Li et al. BIOCHIMIE
- Acetylcholine Attenuates Hydrogen Peroxide-Induced Intracellular Calcium Dyshomeostasis Through Both Muscarinic and Nicotinic Receptors in Cardiomyocytes
- (2016) Siripong Palee et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice
- (2016) Sirinart Kumfu et al. EXPERIMENTAL PHYSIOLOGY
- A combination of an iron chelator with an antioxidant effectively diminishes the dendritic loss, tau-hyperphosphorylation, amyloids-β accumulation and brain mitochondrial dynamic disruption in rats with chronic iron-overload
- (2016) Jirapas Sripetchwandee et al. NEUROSCIENCE
- Mechanisms involved in the in vitro contractile dysfunction induced by different concentrations of ferrous iron in the rat myocardium
- (2016) Renata Andrade Ávila et al. TOXICOLOGY IN VITRO
- Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded Rats
- (2016) Suwakon Wongjaikam et al. PLoS One
- A 5-year follow-up in deferasirox treatment: improvement of cardiac and hepatic iron overload and amelioration in cardiac function in thalassemia major patients
- (2015) E. Cassinerio et al. ANNALS OF HEMATOLOGY
- Current and future treatment strategies for iron overload cardiomyopathy
- (2015) Suwakon Wongjaikam et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Iron and oxidative stress in cardiomyopathy in thalassemia
- (2015) Vasilios Berdoukas et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function
- (2015) Samira Lakhal-Littleton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy
- (2015) Subhash K. Das et al. Scientific Reports
- Chronic Testosterone Replacement Exerts Cardioprotection against Cardiac Ischemia-Reperfusion Injury by Attenuating Mitochondrial Dysfunction in Testosterone-Deprived Rats
- (2015) Wanpitak Pongkan et al. PLoS One
- A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in -thalassemia major (CORDELIA)
- (2014) D. J. Pennell et al. BLOOD
- N-Acetylcysteine Supplementation Reduces Oxidative Stress and DNA Damage in Children with β-Thalassemia
- (2014) Zeynep Canan Ozdemir et al. HEMOGLOBIN
- Combined Therapy of Iron Chelator and Antioxidant Completely Restores Brain Dysfunction Induced by Iron Toxicity
- (2014) Jirapas Sripetchwandee et al. PLoS One
- Oxidative stress in cardiomyocytes contributes to decreased SERCA2a activity in rats with metabolic syndrome
- (2013) Jaime Balderas-Villalobos et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia–reperfusion rat heart
- (2013) Kroekkiat Chinda et al. Diabetes & Vascular Disease Research
- Impairment of calcium ATPases by high glucose and potential pharmacological protection
- (2013) L. Horáková et al. FREE RADICAL RESEARCH
- ZIP14 and DMT1 in the liver, pancreas, and heart are differentially regulated by iron deficiency and overload: implications for tissue iron uptake in iron-related disorders
- (2013) H. Nam et al. HAEMATOLOGICA
- Glutathione Redox System inβ-Thalassemia/Hb E Patients
- (2013) Ruchaneekorn W. Kalpravidh et al. TheScientificWorldJOURNAL
- How I treat transfusional iron overload
- (2012) A. V. Hoffbrand et al. BLOOD
- Combined chelation therapy with deferasirox and deferoxamine in thalassemia
- (2012) Ashutosh Lal et al. BLOOD CELLS MOLECULES AND DISEASES
- Hepcidin-Induced Endocytosis of Ferroportin Is Dependent on Ferroportin Ubiquitination
- (2012) Bo Qiao et al. Cell Metabolism
- Voltage-gated Ca2+ channels as key mediators of iron-transport and iron-overload cardiomyopathy: L-type vs. T-type Ca+ channels
- (2012) Subhash K. Das et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice
- (2012) Sirinart Kumfu et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Effects of Kaempferia parviflora Wall. Ex. Baker and Sildenafil Citrate on cGMP Level, Cardiac Function, and Intracellular Ca2+ Regulation in Rat Hearts
- (2012) Punate Weerateerangkul et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Altered sarcoplasmic reticulum calcium cycling—targets for heart failure therapy
- (2012) Changwon Kho et al. Nature Reviews Cardiology
- Intestinal DMT1 Cotransporter Is Down-regulated by Hepcidin via Proteasome Internalization and Degradation
- (2011) Carole Brasse–Lagnel et al. GASTROENTEROLOGY
- Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines
- (2011) Carol Kilkenny et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Pathogenesis and management of iron toxicity in thalassemia
- (2010) Chaim Hershko Annals of the New York Academy of Sciences
- Monitoring the efficiency of iron chelation therapy: the potential of nontransferrin-bound iron
- (2010) R.C. Hider et al. Annals of the New York Academy of Sciences
- Hepcidin and Disorders of Iron Metabolism
- (2010) Tomas Ganz et al. Annual Review of Medicine
- The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores
- (2010) J. C. Wood et al. BLOOD
- β-Thalassemia Cardiomyopathy
- (2010) Dimitrios T. Kremastinos et al. Circulation-Heart Failure
- T-type calcium channel as a portal of iron uptake into cardiomyocytes of beta-thalassemic mice
- (2010) Sirinart Kumfu et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Mitochondrial dysfunction may explain the cardiomyopathy of chronic iron overload
- (2010) Xueshan Gao et al. FREE RADICAL BIOLOGY AND MEDICINE
- Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging
- (2010) A. Pepe et al. HAEMATOLOGICA
- Iron-Overload Cardiomyopathy: Pathophysiology, Diagnosis, and Treatment
- (2010) Colm J. Murphy et al. JOURNAL OF CARDIAC FAILURE
- High dietary iron reduces transporters involved in iron and manganese metabolism and increases intestinal permeability in calves
- (2010) S.L. Hansen et al. JOURNAL OF DAIRY SCIENCE
- Non-transferrin bound labile plasma iron and iron overload in Sickle Cell Disease: a comparative study between Sickle Cell Disease and β thalassemic patients
- (2009) Ariel Koren et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- High nontransferrin bound iron levels and heart disease in thalassemia major
- (2008) Antonio Piga et al. AMERICAN JOURNAL OF HEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started